Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 13 | Xu ZhenyuChief Scientific Officer | Open-market sale · 10b5-1 plan | SELL | $21K 3,000 sh | Aug 7, 2026 |
| 13 | Allaire JeremyDirector, Chairman and CEO | Open-market sale · 10b5-1 plan | SELL | $32K 526 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 13 | Alclear Investments, LLCDirector, 10% Owner, See Remarks | Open-market sale · 10b5-1 plan | SELL | $74K 1,200 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 13 | Allaire JeremyDirector, Chairman and CEO | Open-market sale · 10b5-1 plan | SELL | $14K 223 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 13 | Allaire JeremyDirector, Chairman and CEO | Open-market sale · 10b5-1 plan | SELL | $22K 352 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 13 | Allaire JeremyDirector, Chairman and CEO | Open-market sale · 10b5-1 plan | SELL | $9,201 153 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 13 | Allaire JeremyDirector, Chairman and CEO | Open-market sale · 10b5-1 plan | SELL | $22K 353 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 13 | Alclear Investments, LLCDirector, 10% Owner, See Remarks | Open-market sale · 10b5-1 plan | SELL | $202K 3,096 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 13 | Allaire JeremyDirector, Chairman and CEO | Open-market sale · 10b5-1 plan | SELL | $32K 526 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 13 | Gallagher CindyCAO | Option exercise | M | — 9,070 sh | Aug 7, 2026 traded Aug 6, 2026 |
| 13 | Allaire JeremyDirector, Chairman and CEO | Open-market sale · 10b5-1 plan | SELL | $16K 261 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 13 | Allaire JeremyDirector, Chairman and CEO | Open-market sale · 10b5-1 plan | SELL | $16K 261 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 13 | Allaire JeremyDirector, Chairman and CEO | Open-market sale · 10b5-1 plan | SELL | $9,201 153 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 13 | Allaire JeremyDirector, Chairman and CEO | Open-market sale · 10b5-1 plan | SELL | $14K 224 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 13 | Allaire JeremyDirector, Chairman and CEO | Open-market sale · 10b5-1 plan | SELL | $32K 525 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 13 | Alclear Investments, LLCDirector, 10% Owner, See Remarks | Open-market sale · 10b5-1 plan | SELL | $154K 2,430 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 13 | Stewart Andrew J.President, GPIC | Grant or award | A | — 16.8K sh | Aug 7, 2026 traded Aug 5, 2026 |
| 13 | Munsch FrederickSVP, Controller and CAO | Grant or award | A | — 9,091 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 13 | Allaire JeremyDirector, Chairman and CEO | Open-market sale · 10b5-1 plan | SELL | $14K 223 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 13 | Allaire JeremyDirector, Chairman and CEO | Open-market sale · 10b5-1 plan | SELL | $9,262 154 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 13 | Gosser TrishaCFO | Option exercise | M | — 10.4K sh | Aug 7, 2026 traded Aug 6, 2026 |
| 13 | Lazar David E.Director, Chief Executive Officer, 10% Owner | Derivative conversion | C | — 124.7K sh | Aug 7, 2026 traded Aug 5, 2026 |
| 13 | Rudyk James DanielDirector | Grant or award | A | — 48.9K sh | Aug 7, 2026 traded Aug 6, 2026 |
| 13 | Eldessouky SamEVP and CFO | Grant or award | A | — 50.3K sh | Aug 7, 2026 traded Aug 5, 2026 |
| 13 | Xu ZhenyuChief Scientific Officer | Open-market sale · 10b5-1 plan | SELL | $49K 7,000 sh | Aug 7, 2026 traded Aug 7, 2026 |
| 13 | Hashad YehiaEVP of R&D and CMO | Grant or award | A | — 21.0K sh | Aug 7, 2026 traded Aug 5, 2026 |
| 13 | Bonnefoy LucPresident, Surgical | Grant or award | A | — 16.8K sh | Aug 7, 2026 traded Aug 5, 2026 |
| 13 | Allaire JeremyDirector, Chairman and CEO | Open-market sale · 10b5-1 plan | SELL | $22K 352 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 13 | Allaire JeremyDirector, Chairman and CEO | Open-market sale · 10b5-1 plan | SELL | $14K 223 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 13 | Bailey A Robert DEVP & Chief Legal Officer | Grant or award | A | — 33.6K sh | Aug 7, 2026 traded Aug 5, 2026 |
| 13 | Allaire JeremyDirector, Chairman and CEO | Open-market sale · 10b5-1 plan | SELL | $32K 525 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 13 | Allaire JeremyDirector, Chairman and CEO | Open-market sale · 10b5-1 plan | SELL | $16K 262 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 13 | Allaire JeremyDirector, Chairman and CEO | Open-market sale · 10b5-1 plan | SELL | $9,262 154 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 13 | Allaire JeremyDirector, Chairman and CEO | Open-market sale · 10b5-1 plan | SELL | $22K 352 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 12 | Saunders Brent LDirector, Chairman of the Board and CEO | Tax withholding | F | $71K 4,231 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 12 | Stewart Frank P.SVP, Advanced Cellular | Tax withholding | F | $215K 2,262 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 12 | Quinton SashaEVP, Pres. CBG | Option exercise | M | $156K 7,549 sh | Aug 7, 2026 traded Aug 6, 2026 |
| 12 | Olson DustinDirector, Chief Executive Officer | Tax withholding | F | $77K 11.1K sh | Aug 7, 2026 traded Aug 5, 2026 |
| 11 | Flammer Martina M.D.Chief Medical Officer | Open-market sale · 10b5-1 plan | SELL | $1.13M 8,895 sh | Aug 7, 2026 traded Aug 6, 2026 |
| 11 | Medway Richard A.General Counsel | Option exercise · 10b5-1 plan | M | $14K 10.0K sh | Aug 7, 2026 traded Aug 5, 2026 |